If you’re considering selling a behavioral health practice, the first question is always the same: what will a buyer actually pay?
The answer is expressed as an EBITDA multiple — the purchase price divided by the practice’s annual adjusted earnings. In 2026, behavioral health practices are selling for 3x to 8x EBITDA depending on sub-vertical, size, and quality. The spread between a 3x and a 7x multiple on the same $2M EBITDA base is $8 million in deal value.
This is the hub resource for behavioral health M&A valuation data. It’s updated annually and cross-referenced with Behavioral Health Business Broker’s active transaction data. Bookmark it, and return each year for updated figures.
What Is an EBITDA Multiple? (Skip If You Know)
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It’s the standard profitability metric used in M&A because it approximates operating cash flow regardless of how the business is financed or structured.
In behavioral health transactions, buyers use adjusted EBITDA — which adds back owner compensation above market rate, personal expenses, one-time items, and non-recurring costs to arrive at a normalized earnings figure that reflects the true earning power of the business.
The formula:
Enterprise Value = Adjusted EBITDA Ã Multiple
Example: A mental health group practice with $3M in adjusted EBITDA and a 5x multiple = $15M enterprise value.
The multiple is set by the market — by the active buyers in each sub-vertical, the availability of capital, and the specific quality attributes of the practice being sold.
2026 EBITDA Multiple Table: Behavioral Health by Sub-Vertical
The table below reflects observed market multiples from 2025—2026 transactions across behavioral health sub-verticals. Ranges represent the realistic low-to-high spectrum; outliers exist at both ends.
| Sub-Vertical | Typical EBITDA Range | Multiple Range (Low) | Multiple Range (High) | Notes |
|---|---|---|---|---|
| ABA Therapy — Platform ($8M+ rev) | $1.5M—$5M+ | 5.5x | 7.5x+ | PE platform buyers; BCBA retention critical |
| ABA Therapy — Add-on ($1M—$8M rev) | $300K—$1.5M | 4x | 6x | Strategic add-ons; geographic fit matters |
| Mental Health Group — Large ($5M+ rev) | $800K—$3M+ | 4.5x | 6.5x | Staff retention, payer mix primary drivers |
| Mental Health Group — Mid ($1M—$5M rev) | $200K—$800K | 3.5x | 5.5x | Local/regional strategics, smaller PE |
| Mental Health Solo/Small (<$1M rev) | <$200K | 1x—1.5x rev | 2x rev | Often revenue multiples, not EBITDA |
| Addiction Treatment — Residential | $1M—$8M+ | 5x | 8x+ | Census + accreditation = premium |
| Addiction Treatment — PHP/IOP | $500K—$3M | 4x | 6.5x | Payer mix, MAT capability critical |
| Outpatient Behavioral Health (Mixed) | $300K—$2M | 3x | 5.5x | Depends on service mix, size, growth |
| Psychiatric Services / Prescriber Groups | $500K—$3M+ | 4x | 7x | Telehealth scale, board-certified prescribers |
Table reflects 2025—2026 observed market data. Multiples vary based on deal-specific factors including size, buyer type, market conditions, and practice quality.
Why Multiples Vary So Dramatically Within the Same Sub-Vertical
Two ABA therapy practices. Same revenue. Same geography. Different valuations by 2x—3x. How?
The multiple premium reflects buyer-perceived risk and growth potential. Here are the concrete factors that move you up or down within the range:
Factors that push multiples higher:
- Revenue scale above $5M (size premium)
- Adjusted EBITDA margin above 20%
- Strong BCBA or licensed staff retention with tenure and agreements
- Commercial-dominant payer mix (70%+ commercial)
- Active growth trajectory (20%+ YoY revenue growth)
- CARF, Joint Commission, or BHCOE accreditation
- Multi-site footprint or clear organic expansion opportunity
- Clean financials with no audit history, no payer recoupments
- Lease with 3+ years remaining and assignment rights
Factors that suppress multiples:
- Owner is primary or sole clinician (key-person risk)
- Medicaid-heavy payer mix (50%+)
- Flat or declining revenue in trailing 12—24 months
- EBITDA margin below 12%
- Lease expiring within 12 months
- Licensing violations or active investigations
- Single referral source concentration (>30% from one source)
- Staff turnover above 30% annually
The gap between “addressed all suppressors” and “has multiple suppressors” is often 1.5x—2.5x — which can represent millions of dollars on a mid-size practice.
[LINK: Identify which of the 5 key factors are suppressing your practice’s value — /behavioral-health-practice-value]
ABA Therapy Multiples: The PE Roll-Up Premium
ABA therapy is the most actively consolidated behavioral health sub-vertical, and PE roll-up activity continues to drive premium multiples for well-positioned practices.
Current market dynamics:
- 15—20 active PE-backed ABA platforms are acquiring in 2026
- Platform practices ($8M+ revenue) with strong clinical infrastructure command 6x—7.5x+
- Add-on acquisitions ($1M—$5M revenue) typically receive 4x—5.5x, with premium for strategic geographic fit
- BCBAs shortage continues to create premium for practices with stable, deep clinical teams
What’s changed since 2023:
- Quality of earnings (QofE) diligence has become standard on all transactions, even smaller deals
- Buyers are more conservative on Medicaid-heavy books as state rate pressures have increased
- Outcomes data documentation is increasingly expected in larger deals
- Earnout structures have become more common as buyers manage post-close revenue risk
[LINK: Deep dive on ABA therapy practice valuation and what buyers evaluate — /aba-therapy-practice-valuation]
Mental Health Practice Multiples: Size and Staff Are Everything
Mental health group practice M&A activity has grown substantially since 2021, with PE-backed consolidators building regional platforms across the country.
Current market dynamics:
- Group practices with $3M+ revenue and 10+ employed clinicians attract the highest buyer interest and best multiples
- Solo practices and micro-groups (<$1M revenue) are typically valued at 1x—2x annual gross revenue (goodwill-based)
- Telehealth-hybrid practices attract tech-aware strategic buyers who may pay above standard multiples for the platform infrastructure
- Staff retention agreements and non-solicitation provisions are increasingly non-negotiable for large deals
Key mental health valuation metrics buyers track:
- Revenue per clinician (target: $150K—$250K+ annually)
- Client retention rate and average episode length
- Payer-specific collection rate and denial rates
- Owner clinical dependency percentage
[LINK: Complete guide to selling a mental health practice step by step — /how-to-sell-mental-health-practice]
Addiction Treatment Multiples: The CARF Premium and Census Math
Addiction treatment — particularly residential and PHP programs — remains among the highest-multiple segments in behavioral health when programs are well-run and properly structured.
Current market dynamics:
- Residential programs with CARF or Joint Commission accreditation, census above 75%, and commercial-dominant payer mix consistently achieve 6x—8x EBITDA
- PHP/IOP programs with strong OP step-down and alumni programs reach 5x—6.5x
- Programs without accreditation face 1x—1.5x multiple discount and shrinking buyer pool
- IMD exclusion waiver expansion continues to improve Medicaid residential revenue in participating states (currently 37+ states have approved waivers)
Buyer math on census: A 30-bed residential program at 75% occupancy (22.5 ADC) à $900/day commercial rate à 365 days = approximately $7.4M in gross residential revenue. Net of contractual adjustments and payer mix blending, programs of this size often generate $1.5M—$2.5M in EBITDA. At 6x—7x, enterprise value is $9M—$17.5M.
What’s changed since 2023:
- Out-of-network billing at aggressive rates has largely been curtailed by payer and regulatory pressure — programs dependent on OON arbitrage have seen significant multiple compression
- MAT integration is now essentially expected by both payers and buyers; non-MAT programs face buyer pool reduction
- Referral source diversification scrutiny has intensified post-patient-broker regulation
[LINK: Full buyer criteria for addiction treatment center acquisitions — /addiction-treatment-center-acquisition]
Outpatient Behavioral Health: The Mixed-Service Segment
Outpatient behavioral health practices that blend multiple service lines — therapy, psychiatry, psychological testing, case management — present a more complex valuation picture.
Current market dynamics:
- Multi-service outpatient practices are attractive to acquirers building full-spectrum behavioral health platforms
- Practices with a psychiatry/prescriber component command a premium relative to therapy-only practices at similar revenue
- Integration of SUD and mental health services (“co-occurring” programs) is a differentiating factor that growing numbers of PE buyers value
- Group practice networks using telehealth as a meaningful revenue channel are increasingly attractive for technology-driven platforms
Valuation anchors:
- $1M—$3M revenue outpatient practices: 3x—4.5x EBITDA if well-structured, or 0.75x—1.25x revenue for smaller practices
- $3M—$10M revenue multi-service practices: 4x—6x if staff is retained, payer mix is balanced, and growth is demonstrable
- $10M+ multi-service platforms: 5x—7x with PE buyer competition
How Transaction Size Affects the Multiple: The Size Premium
Buyers apply a “size premium” to larger transactions — and it’s not arbitrary. Larger practices have:
- Greater management depth (less key-person risk)
- More scalable infrastructure (systems, billing, HR)
- Larger EBITDA bases (same multiple à larger base = more value creation potential for PE)
- Greater margin expansion potential post-acquisition
The size premium is typically 0.5x—1.5x across the relevant EBITDA ranges, and it is one of the most predictable factors in behavioral health M&A. The practical implication: if your practice is generating $500K in EBITDA, investing 12—18 months to grow to $750K—$1M EBITDA before going to market could yield a meaningfully higher multiple and a larger base — a compounded improvement in total deal value.
What These Multiples Mean in Dollar Terms
| Adjusted EBITDA | Multiple | Enterprise Value |
|---|---|---|
| $500,000 | 4x | $2,000,000 |
| $750,000 | 4.5x | $3,375,000 |
| $1,000,000 | 5x | $5,000,000 |
| $1,500,000 | 5.5x | $8,250,000 |
| $2,000,000 | 6x | $12,000,000 |
| $3,000,000 | 6.5x | $19,500,000 |
| $5,000,000 | 7x | $35,000,000 |
These dollar values are before working capital adjustments, debt payoffs, and transaction costs. A qualified M&A advisor can give you a net-to-seller estimate once those variables are known.
2026 Market Conditions: What’s Driving Behavioral Health M&A
Capital availability: Private equity dry powder (capital raised but not yet deployed) remains elevated heading into 2026. Behavioral health continues to attract LP capital as a recession-resistant, demand-driven sector.
Interest rate environment: The elevated interest rate cycle that began in 2022—2023 has cooled somewhat but continues to affect leveraged buyout economics. Buyers are disciplined about leverage multiples, which has modestly compressed the very top of the range versus 2021 peak multiples.
Regulatory attention: CMS and state Medicaid agencies have increased scrutiny on behavioral health billing practices. Programs with clean compliance histories are benefiting from a “flight to quality” among buyers who want to avoid regulatory risk.
WORKFORCE: The national BCBA shortage, licensed counselor shortage, and psychiatric prescriber shortage continue to affect valuations — staff depth and retention are more important than ever.
Telehealth normalization: Post-pandemic telehealth flexibilities have largely been codified into permanent policy. Practices with well-integrated telehealth infrastructure are more attractive than pure brick-and-mortar programs in most sub-verticals.
Frequently Asked Questions: Behavioral Health EBITDA Multiples
What EBITDA multiple should I expect for my behavioral health practice in 2026?
Multiples range from 3x to 8x+ depending on sub-vertical, size, and quality. ABA therapy practices range 4x—7.5x; mental health groups 3x—6.5x; addiction residential 5x—8x; outpatient behavioral health 3x—5.5x. The primary drivers of where you fall within the range are practice size, payer mix, clinical staff stability, accreditation status, and growth trajectory.
Are behavioral health M&A multiples higher or lower than in previous years?
2026 multiples are slightly below the 2021 peak — when unprecedented PE activity and low interest rates drove outlier multiples at the top of each range. However, 2026 multiples remain historically strong and well above pre-2019 levels. Demand for quality practices continues to exceed supply in most sub-verticals.
How do I calculate my practice’s adjusted EBITDA?
Start with net income (or net loss). Add back: interest expense, taxes paid through the business, depreciation and amortization, owner compensation above market rate, personal expenses through the business, and one-time non-recurring items. The result is adjusted EBITDA — the figure buyers will use to apply a multiple.
Do I need to know my EBITDA to get a valuation from Behavioral Health Business Broker?
No. We’ll help you calculate it. Share your 3 most recent years of P&L statements (or Schedule C / K-1 tax returns), and our team will prepare a normalized EBITDA analysis as part of your no-cost confidential valuation.
Why do larger practices receive higher EBITDA multiples than smaller ones?
Larger practices command a “size premium” because they have more management infrastructure, lower key-person risk, larger EBITDA bases for PE value creation, and greater scalability. The size premium in behavioral health is typically 0.5x—1.5x across meaningful revenue thresholds.
Are ABA therapy practices still a strong sell in 2026?
Yes. ABA therapy remains one of the most actively acquired behavioral health sub-verticals in 2026. PE platform consolidation is ongoing, demand for quality practices with BCBA depth and commercial payer mix continues to exceed supply, and multiples have held in the 4x—7x range for well-positioned practices.
What’s the difference between enterprise value and what I’ll actually take home from a sale?
Enterprise value is the total deal price. What you take home is net of: debt paid off at closing (lines of credit, term loans, equipment financing), working capital adjustments, seller-side transaction costs (legal, advisory fees, tax), and any rollover equity you’ve elected to retain. A qualified M&A advisor and transaction attorney will help you understand the net-to-seller figure specific to your deal.
[LINK: ABA therapy valuation deep dive: what makes a practice worth 5x—7x — /aba-therapy-practice-valuation]
[LINK: How to sell a mental health practice: step-by-step guide — /how-to-sell-mental-health-practice]
[LINK: The 5 factors that drive behavioral health practice value — /behavioral-health-practice-value]
[LINK: Addiction treatment center acquisitions: buyer criteria and deal drivers — /addiction-treatment-center-acquisition]